Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
- 30 April 2010
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 68 (1), 105-110
- https://doi.org/10.1016/j.lungcan.2009.05.010
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
- Cancer Research Institute
- University of Occupational and Environmental Health
This publication has 43 references indexed in Scilit:
- A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung CancersJournal of Thoracic Oncology, 2008
- L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung CancerClinical Cancer Research, 2007
- HLA class I antigen expression is associated with a favorable prognosis in early stage non‐small cell lung cancerCancer Science, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Identification of HLA‐A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lungInternational Journal of Cancer, 2006
- Haplotype Loss of HLA Class I Antigen as an Escape Mechanism from Immune Attack in Lung CancerCancer Research, 2005
- Tissue Microarray Evaluation of Melanoma Antigen E (MAGE) Tumor-Associated Antigen ExpressionAnnals of Surgery, 2002
- Histological typing of lung and pleural tumours: third editionJournal of Clinical Pathology, 2001
- Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: Frequency and prognostic significanceEuropean Journal of Cancer, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991